Alemayehu C, Mitchell G, Nikles J, Aseffa A, Clavarino A
BMC Health Serv Res. 2018; 18(1):624.
PMID: 30089496
PMC: 6083528.
DOI: 10.1186/s12913-018-3410-5.
Summers A, Ruderman C, Leung F, Slater M
BMC Med Educ. 2017; 17(1):175.
PMID: 28938883
PMC: 5610475.
DOI: 10.1186/s12909-017-1015-z.
Ravi Shankar P, Herz B, Dubey A, Hassali M
Indian J Pharmacol. 2016; 48(Suppl 1):S29-S32.
PMID: 28031604
PMC: 5178050.
DOI: 10.4103/0253-7613.193309.
Godman B, Shrank W, Wettermark B, Andersen M, Bishop I, Burkhardt T
Pharmaceuticals (Basel). 2016; 3(8):2470-2494.
PMID: 27713363
PMC: 4033935.
DOI: 10.3390/ph3082470.
Bashaar M, Hassali M, Saleem F
J Pharm Policy Pract. 2015; 8(1):16.
PMID: 26078869
PMC: 4467055.
DOI: 10.1186/s40545-015-0037-3.
The cost of multiple sclerosis drugs in the US and the pharmaceutical industry: Too big to fail?.
Hartung D, Bourdette D, Ahmed S, Whitham R
Neurology. 2015; 84(21):2185-92.
PMID: 25911108
PMC: 4451044.
DOI: 10.1212/WNL.0000000000001608.
The experiences of implementing generic medicine policy in eight countries: A review and recommendations for a successful promotion of generic medicine use.
Hassali M, Alrasheedy A, McLachlan A, Nguyen T, Al-Tamimi S, Ibrahim M
Saudi Pharm J. 2015; 22(6):491-503.
PMID: 25561861
PMC: 4281627.
DOI: 10.1016/j.jsps.2013.12.017.
A comparison of drug formularies and the potential for cost-savings.
Kjos A, Schommer J, Yuan Y
Am Health Drug Benefits. 2014; 3(5):321-30.
PMID: 25126325
PMC: 4106615.
Variability in drug formularies and implications in decision support.
Stephens M, Finnell J, Simonaitis L, Overhage J
AMIA Annu Symp Proc. 2011; 2011:1327-36.
PMID: 22195194
PMC: 3243218.
Ticagrelor versus genotype-driven antiplatelet therapy for secondary prevention after acute coronary syndrome: a cost-effectiveness analysis.
Crespin D, Federspiel J, Biddle A, Jonas D, Rossi J
Value Health. 2011; 14(4):483-91.
PMID: 21669373
PMC: 3384486.
DOI: 10.1016/j.jval.2010.11.012.
Generic and therapeutic substitution: ethics meets health economics.
Simoens S
Int J Clin Pharm. 2011; 33(3):469-70.
PMID: 21431935
DOI: 10.1007/s11096-011-9500-7.
Impact of generic substitution decision support on electronic prescribing behavior.
Stenner S, Chen Q, Johnson K
J Am Med Inform Assoc. 2010; 17(6):681-8.
PMID: 20962131
PMC: 3000753.
DOI: 10.1136/jamia.2009.002568.
Rationale and design of the Study Assessing the Effect of Cardiovascular Medications Provided as Low-cost, Evidence-based Generic Samples (SAMPLES) trial.
Shrank W, Choudhry N, Solomon D, Snedden T, Lee T, Glynn R
Am Heart J. 2009; 157(4):613-9.
PMID: 19332186
PMC: 2683845.
DOI: 10.1016/j.ahj.2008.12.006.
Patients' perceptions of generic medications.
Shrank W, Cox E, Fischer M, Mehta J, Choudhry N
Health Aff (Millwood). 2009; 28(2):546-56.
PMID: 19276015
PMC: 2748784.
DOI: 10.1377/hlthaff.28.2.546.
Patient, physician, pharmacy, and pharmacy benefit design factors related to generic medication use.
Shrank W, Stedman M, Ettner S, DeLapp D, Dirstine J, Brookhart M
J Gen Intern Med. 2007; 22(9):1298-304.
PMID: 17647066
PMC: 2219782.
DOI: 10.1007/s11606-007-0284-3.
